Shields John L. sold $83K of EVER

Shields John L. sold 3,126 shares of EverQuote, Inc. (EVER) at an average of $26.39 ($26.30–$26.81) across 2 trades on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Shields John L.
Published Aug 27, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Neutral
high confidence
Mentioned
$EVER
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERNeutralLow
01

Why it matters

The disclosed sale is routine and does not suggest new information about the company's fundamentals.

02

Market read

A small insider sale with limited market impact; primarily of interest to compliance and monitoring teams.

03

Timing

filed 2026-08-27

Relevance 2/10Novelty 4/10Timing: filed 2026-08-27

Background

EverQuote (NASDAQ:EVER) is an online insurance marketplace. Insider transactions are disclosed via Form 4 filings.

Company-level read

Ticker impact

$EVERNeutralHigh confidence
Context

Director John L. Shields sold 3,126 shares of EverQuote for $82,508 via a 10b5-1 plan, reducing his stake to 31,198 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale amount is small relative to market cap and follows a pre‑arranged plan, indicating no urgent market signal.

Key entities

  • John L. Shields

    Insider who sold shares under a 10b5-1 plan.

  • EverQuote, Inc.

    Subject of the Form 4 filing.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.